N-[(2R)-3-(3-cyanophenyl)-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]-8-fluoro-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide C23 H25 F N4 O3 S HMBXWXQQVHJMOO-JOCHJYFZSA-N
AA [auth B] BA [auth B] CA [auth B] DA [auth B] G [auth A]
AA [auth B], BA [auth B], CA [auth B], DA [auth B], G [auth A], GA [auth C], H [auth A], HA [auth C], I [auth A], IA [auth C], J [auth A], JA [auth C], K [auth A], KA [auth C], L [auth A], LA [auth C], M [auth A], MA [auth C], N [auth A], NA [auth C], O [auth A], OA [auth C], P [auth A], Q [auth A], R [auth A], RA [auth D], S [auth A], SA [auth D], T [auth A], TA [auth D], UA [auth D], VA [auth D], W [auth B], WA [auth D], X [auth B], Y [auth B], Z [auth B]